|Articles|March 1, 2006

Vaccines: Never-ending story

Pediatricians, take note: At its February 22 meeting, The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) made these important recommendations:

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes

ByJamie Wood, MD

June 4th 2026

Top 5 pediatric health headlines you missed in May 2026

ByMorgan Ebert, Executive Editor

June 3rd 2026

Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD

ByColleen Cotton, MD, FAAD

June 3rd 2026

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

ByJulie Khlevner, MD, AGAF

June 3rd 2026

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

ByMorgan Ebert, Executive Editor

June 2nd 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Vaccines: Never-ending story

Related Content

Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes

Top 5 pediatric health headlines you missed in May 2026

Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

Top 5 pediatric health headlines you missed in May 2026

Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD

FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa